CVS Health Corporation (NYSE:CVS) produced a 6.01% rally since recording the worst price of $51.72. Thanks to the latest -0.87% decrease, it now trades at $54.83. Throughout the trading on 7/9/2019, the share price floated between $54.655 and $55.37. This company shares are 25.3% off its target price of $68.7 and the current market capitalization stands at $71.56B. The recent change has given its price a 1.17% lead over SMA 50 and -33.26% deficit over its 52-week high. The stock witnessed 1.69% gains, 1.26% gains and -20.08% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CVS’s volatility during a week at 1.51% and during a month it has been found around 1.77%.
What Does CVS Health Corporation (CVS) Do?
The company describes itself in regulatory filings as, “CVS Health Corp. engages in the provision of health care services. It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management capabilities. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.” [Text can be found here: https://www.marketwatch.com/investing/stock/CVS/profile under company description.]CVS Health Corporation (CVS) Top Holders
Institutional investors currently hold around $56.37 billion or 80.9% in CVS stock. Look at its top three institutional owners: Vanguard Group Inc owns $5.6 billion in CVS Health Corporation, which represents roughly 7.82% of the company’s market cap and approximately 9.93% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 92,526,527 shares of the stock are valued at $5.12 billion. The third largest holder is State Street Corp, which currently holds $3.39 billion worth of this stock and that ownership represents nearly 4.74% of its market capitalization.
At the end of March reporting period, 994 institutional holders increased their position in CVS Health Corporation (NYSE:CVS) by some 83,383,860 shares, 802 decreased positions by 124,525,414 and 105 held positions by 811,189,607. That puts total institutional holdings at 1,019,000,000 shares, according to SEC filings. The stock grabbed 143 new institutional investments totaling 4,910,415 shares while 204 institutional investors sold out their entire positions totaling 26,897,912 shares.CVS Health Corporation (NYSE:CVS) Insider Trades
Multiple company employees have indulged in significant insider trading. CVS Health Corporation disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director BROWN C DAVID II has acquired 10,000 shares of CVS Health Corporation (CVS) in the trading session dated Mar. 11, 2019. These shares are worth $531,800 and were traded at $53.18 each. The SEC filing shows that AGUIRRE FERNANDO performed a purchase of 1,900 shares. The Director added these shares by way of transaction on Mar. 11, 2019. The company’s shares were assimilated at $53.59 per share worth to an investment of some $101,821 to the account of AGUIRRE FERNANDO.
Director, LUDWIG EDWARD J, purchased 2,000 common shares of CVS Health Corporation (CVS) in the open market. In a transaction dated Mar. 08, 2019, the shares were bought at an average price of $52.8, giving away a sum of $105,600. After this purchase, 18,457 common shares of CVS are directly owned by the insider, with total stake valued at $1,011,997.
In the transaction dated Mar. 08, 2019, a great number of shares acquired came courtesy the Director; DORMAN DAVID W added a total of 9,600 shares at an average price of $52.71, amounting to approximately $506,016. The insider now directly owns 122,302 shares worth $6,705,819.CVS Health Corporation (CVS) Analyst Guide
Several analysts have released their opinion on CVS Health Corporation (NYSE:CVS), with 8 analysts believing it is a strong buy. Whereas 10 of them predict the stock is a hold. Also, there are 9 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.07 average brokerage recommendation [T1].